Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1351 studies found for:    chelation
Show Display Options
Rank Status Study
1 Not yet recruiting Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)
Conditions: Beta-thalassemia;   Serum Ferritin;   Iron Chelation Therapy
Intervention: Drug: desferal, ferriprox, blood transfusion
2 Unknown  Role of Vitamin C to Augment Iron Chelation With DFP or DFX
Conditions: Vitamin c;   Thalassemia Major;   Iron Chelation
Interventions: Drug: Vitamin C, Defriprone, deferisarox;   Drug: deferiprone , deferesarox
3 Not yet recruiting An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients
Condition: Beta Thalassemia Major
Intervention: Drug: Deferiprone
4 Completed Combo Chelation Trial
Conditions: Thalassemia;   Iron Overload
Intervention: Drug: Combo Chelation with Deferasirox (Exjade) and Desferal (DFO)
5 Completed Effects of Iron Loading and Iron Chelation Therapy on Innate Immunity During Human Endotoxemia
Conditions: Systemic Inflammatory Process;   Anemia
Interventions: Drug: iron sucrose;   Drug: Deferasirox;   Drug: endotoxin;   Drug: Placebo
6 Completed
Has Results
Trial to Assess Chelation Therapy (TACT)
Condition: Coronary Artery Disease
Interventions: Drug: EDTA;   Drug: EDTA Placebo;   Dietary Supplement: High Dose Vitamin;   Dietary Supplement: High Dose Vitamin Placebo
7 Not yet recruiting Trial to Assess Chelation Therapy 2
Conditions: Diabetes;   Myocardial Infarction
Interventions: Drug: disodium EDTA;   Dietary Supplement: Oral Multi Vitamins/Minerals (OMVM);   Drug: Placebo disodium EDTA;   Dietary Supplement: Placebo Oral Multi Vitamins/Minerals (OMVM)
8 Completed Amlodipine for Myocardial Iron in Thalassemia
Condition: Thalassemia
Interventions: Drug: Standard Chelation;   Drug: Amlodipine
9 Recruiting Reproductive Capacity and Iron Burden in Thalassemia
Interventions: Other: Blood Draw/Semen Exam;   Other: Retrospective data/Chart Review/Relevant Clinical Results;   Other: Pituitary MRI
10 Completed Combination Iron Chelation Therapy
Conditions: Iron Overload;   Thalassemia
Intervention: Drug: Combination Iron Chelation Therapy
11 Completed Iron-Chelating Therapy and Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Iron chelating intervention
12 Withdrawn Penicillamine Chelation for Children With Lead Poisoning
Conditions: Lead Poisoning;   Vitamin D Deficiency
Interventions: Device: d-penicillamine;   Drug: placebo
13 Completed Long-Term Lead Chelation Therapy and Progressive Renal Insufficiency
Condition: Urologic Disease
Intervention: Drug: calcium disodium EDTA (edetate calcium disodium)
14 Recruiting Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease
Condition: Parkinson Disease
Interventions: Drug: Deferiprone;   Drug: Placebo
15 Unknown  Environmental Exposure to Lead and Its Health Effects on Patients With Maintenance Hemodialysis
Conditions: Anemia;   Malnutrition;   Inflammation;   Lead Poisoning
Intervention: Drug: lead chelation therapy
16 Completed Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major
Conditions: Iron Overload;   Cardiomyopathy
Interventions: Drug: Deferoxamine and Deferiprone;   Drug: Deferoxamine
17 Withdrawn Mercury Chelation to Treat Autism
Conditions: Autism;   Asperger's Disorder;   Child Development Disorders, Pervasive
Intervention: Drug: DMSA
18 Recruiting Amlodipine as Adjuvant Treatment to Iron Chelation for Prevention of Cardiac Iron Overload in Thalassemia Patients
Conditions: Beta-Thalassemia;   Iron Overload
Interventions: Drug: Amlodipine;   Drug: Deferasirox
19 Completed
Has Results
Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients
Conditions: Anemia;   Hemosiderosis
Intervention: Drug: Deferasirox
20 Completed
Has Results
An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload
Condition: Transfusional Iron Overload in β-thalassemia
Intervention: Drug: Deferasirox

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years